Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7442071 | 0.77 | DGAT1 (0.32) | — | |
| SCHEMBL1714208 | 0.74 | DGAT1 (0.50) | CTSK | |
| SCHEMBL13551145 | 0.74 | DGAT1 (0.33) | — | |
| SCHEMBL12727292 | 0.74 | DGAT1 (0.39) | — | |
| Ammonia Solution, Strong SCHEMBL1033675 | 0.72 | GAA (0.42) | CTSK | |
| Hydrochloric Acid SCHEMBL28000852 | 0.72 | DGAT1 (0.48) | CTSK | |
| SCHEMBL12590727 | 0.71 | MMP8 (0.37) | — | |
| SCHEMBL3416095 | 0.70 | DGAT1 (0.31) | — | |
| SCHEMBL19558503 | 0.70 | DGAT1 (0.31) | — | |
| SCHEMBL14839078 | 0.70 | DGAT1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7217814-B2 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20050124804-A1 | Methods of producing phosphitylated compounds | WERNER CHRISTIAN (DE) | 2005-06-09 | — | — | US | disclosed |
| US-6894158-B2 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. (US) | 2005-05-17 | — | — | US | disclosed |
| EP-1476407-A2 | METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS | Honeywell International Inc. (US) | 2004-11-17 | — | — | EP | disclosed |
| US-20030232980-A1 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. | 2003-12-18 | — | — | US | disclosed |
| WO-2003072586-A2 | METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS | HONEYWELL INTERNATIONAL INC. (US) | 2003-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124804-A1 | Methods of producing phosphitylated compounds | PHOSPHO1, INPPL1, PLCB3 | CTSK 694/4885 |
| US-20030232980-A1 | Methods of producing phosphitylated compounds | PHOSPHO1, INPPL1, PLCG1 | CTSK 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.